Suspension of trading of Medincell shares, trading to resume tomorrow
May 8, 2024
Previous PostTeva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
Next Post[Replay] Videoconference • Collaboration with AbbVie (French)
